1-3 of 3
Jean M. Whaley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Monoclonal Antibody Is an Allosteric Insulin Receptor Antagonist That Induces Insulin Resistance

Anne M. Cieniewicz, Thomas Kirchner, Simon A. Hinke, Rupesh Nanjunda, Katharine D’Aquino, Ken Boayke, Philip R. Cooper, Robert Perkinson, Mark L. Chiu, Stephen Jarantow, Dana L. Johnson, Jean M. Whaley, Eilyn R. Lacy, Russell B. Lingham, Yin Liang, Anthony J. Kihm
Journal: Diabetes
Diabetes 2017;66(1):206–217
https://doi.org/10.2337/db16-0633
Published: 26 October 2016
View article titled, Novel Monoclonal Antibody Is an Allosteric Insulin Receptor Antagonist That Induces Insulin Resistance
Open the PDF for Novel Monoclonal Antibody Is an Allosteric Insulin Receptor Antagonist That Induces Insulin Resistance in another window
Includes: Supplementary data
Journal Articles

SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function

Michael J. Jurczak, Hui-Young Lee, Andreas L. Birkenfeld, Francois R. Jornayvaz, David W. Frederick, Rebecca L. Pongratz, Xiaoxian Zhao, Gilbert W. Moeckel, Varman T. Samuel, Jean M. Whaley, Gerald I. Shulman, Richard G. Kibbey
Journal: Diabetes
Diabetes 2011;60(3):890–898
https://doi.org/10.2337/db10-1328
Published: 21 February 2011
View article titled, SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
Open the PDF for SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function in another window
Includes: Supplementary data
Journal Articles

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

Songping Han, Deborah L. Hagan, Joseph R. Taylor, Li Xin, Wei Meng, Scott A. Biller, John R. Wetterau, William N. Washburn, Jean M. Whaley
Journal: Diabetes
Diabetes 2008;57(6):1723–1729
https://doi.org/10.2337/db07-1472
Published: 01 June 2008
View article titled, Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
Open the PDF for Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats in another window
Includes: Supplementary data